ASHP therapeutic position statement on strategies for preventing and treating multidrug-resistant tuberculosis.
MDR-TB is usually the result of mismanagement of tuberculosis and requires intensive and costly therapeutic strategies. Prevention is the most effective means of managing MDR-TB. Pharmacists and other health professionals should work together to plan and implement programs for effective screening and therapy of tuberculosis. DOT is an important therapeutic tool that should be considered in all patients. Interdisciplinary management programs can be effective in reducing the rate of drug resistance and maximizing efficacy.
D006801:Humans; D008403:Mass Screening; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D010348:Patient Care Team / Q000458:organization & administration / Q000592:standards; D010349:Patient Compliance; D010353:Patient Education as Topic; D012307:Risk Factors; D012957:Societies, Pharmaceutical / Q000592:standards*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000517:prevention & control